N-3 polyunsaturated fatty acids modulate in-vitro T cell function in type I diabetic patients

Lipids

Volumn 43, Issue 6, 2008, Pages 485-497

  Merzouk, Sid Ahmed ^a   Saker, Meriem ^a   Reguig, Karima Briksi ^b   Soulimane, Nassima ^a   Merzouk, Hafida ^a   Guermouche, Baya ^a   Berrouiguet, Abdelsslam Yahia ^c   Hichami, Aziz ^d   Narce, Michel ^e   Khan, Naim Akhtar ^d  

^a UNIVERSITY OF TLEMCEN   (Algeria)

^b UNIVERSITY OF SIDI BEL ABBES   (Algeria)

^c Ctr Hosp Universitaire de Tlemcen   (Algeria)

^d UNIVERSITÉ DE BOURGOGNE   (France)

^e Chu   (France)

Author keywords

Diabetes; Docosahexaenoic acid; Eicosapentaenoic acid; Interleukins; Lymphocytes; Oxidant status; Polyunsaturated fatty acids

Indexed keywords

ARACHIDONIC ACID; CATALASE; DOCOSAHEXAENOIC ACID; FATTY ACID; GLUTATHIONE; HYDROPEROXIDE; ICOSAPENTAENOIC ACID; INTERLEUKIN 2; INTERLEUKIN 4; MEMBRANE PHOSPHOLIPID; OMEGA 3 FATTY ACID; SUPEROXIDE DISMUTASE;

ADULT; ARTICLE; CELL LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DIABETIC PATIENT; ENZYME ACTIVITY; FEMALE; GLUCOSE TRANSPORT; HUMAN; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE CULTURE; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MALE; OXIDATIVE STRESS;

ADULT; BLOOD GLUCOSE; CHOLESTEROL; DIABETES MELLITUS, TYPE 1; FATTY ACIDS, OMEGA-3; FEMALE; GLUTATHIONE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYDROGEN PEROXIDE; MALE; PHOSPHOLIPIDS; T-LYMPHOCYTES; TRIGLYCERIDES;

EID: 49349106092     PISSN: 00244201     EISSN: 15589307     Source Type: Journal    
DOI: 10.1007/s11745-008-3176-3     Document Type: Article

References (47)

1. M Itoh 1989 Immunological aspects of diabetes mellitus: prospects for pharmacological modification Pharmacol Ther 44 351 406
2. BR Shah JE Hux 2003 Quantifying the risk of infectious diseases for people with diabetes Diabetes Care 26 510 513
3. M Balasubramanyam C Premanand V Mohan 2002 The lymphocyte as a cellular model to study insights into the pathophysiology of diabetes and its complications Ann NY Acad Sci 958 399 402
4. R Otton JR Mendonca R Curi 2002 Diabetes causes marked changes in lymphocyte metabolism J Endocrinol 174 55 61
5. M Delamaire D Maugendre M Moreno MC Le Goff H Allannic B Genetet 1997 Impaired leucocyte functions in diabetic patients Diabet Med 14 29 34
6. S Lindley CM Dayan A Bishop BO Roep M Peakman TIM Tree 2005 Defective suppressor function in CD4_CD25_T-Cells from patients with type 1 diabetes Diabetes 54 92 99
7. WH Hoffman SW Helman G Passmore 2001 Acute activation of peripheral lymphocytes during treatment of diabetic ketoacidosis J Diabet Complicat 15 144 149
8. V Seyfert-Margolis TD Gisler AL Asare RS Wang HM Dosch B Brooks-Worrell GS Eisenbarth JP Palmer CJ Greenbaum S Gitelman G Nepom JA Bluestone KC Herold 2006 Analysis of T-Cell assays to measure autoimmune responses in subjects with type 1 diabetes Diabetes 55 2588 2594
9. S Arif TI Tree TP Astill JM Tremble AJ Bishop CM Dayan BO Roep M Peakman 2004 Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health J Clin Invest 113 451 463
10. N Hill N Sarvetnick 1996 Cytokines: promoters and dampeners of autoimmunity Curr Opin Immunol 14 791 792
11. M Tiittanen JT Huupponen M Knip O Vaarala 2006 Insulin treatment in patients with Type 1 diabetes induces upregulation of regulatory T-cell markers in peripheral blood mononuclear cells stimulated with insulin in vitro Diabetes 55 3446 3454
12. C Giordano F Panto C Caruso 1989 Interleukin-2 and soluble interleukin-2 receptor secretion defect in vitro in newly diagnosed type 1 diabetic patients Diabetes 38 310 315
13. DA Cantrell KA Smith 1984 The interleukin-2 T cell system: a new cell growth model Science 224 1312 1316
14. AR Saltiel 1990 Second messengers of insulin action Diabetes Care 13 244 256
15. P Hunt DD Eardley 1986 Suppressive effects of insulin and insulin-like growth factor-1 (IGF1) on immune responses J Immunol 136 3994 3999
16. P Dandona A Aljada P Mohanty 2002 The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm Diabetologia 45 924 930
17. DB Jump 2002 The biochemistry of n-3 polyunsaturated fatty acids J Biol Chem 277 8755 8758
18. Q Li M Wang L Tan C Wang J Ma N Li G Xu J Li 2005 Docosahexaenoic acid changes lipid composition and interleukin-2 receptor signaling in membrane rafts J Lipid Res 46 1904 1913
19. LS Harbige 1998 Dietary n-6 and n-3 fatty acids in immunity and autoimmune disease Proc Nutr Soc 57 555 562
20. DS Kelly 2001 Modulation of human immune and inflammatory responses by dietary fatty acids Nutrition 17 669 673
21. CA Jolly YH Jiang RS Chapkin DN Mc Murray 1997 Dietary n-3 polyunsaturated fatty acids suppress murine lymphoproliferation, interleukin-2 secretion, and the formation of diacylglycerol and ceramide J Nutr 127 37 43
22. PC Calder EA Newsholme 1992 Polyunsaturated fatty acids suppress human peripheral blood lymphocyte proliferation and interleukin-2 production Clin Sci 82 695 700
23. TM Stulnig 2003 Immunomodulation by polyunsaturated fatty acids: mechanisms and effects Int Arch Allergy Immunol 132 310 321
24. M Zeyda AB Szekeres R Saemann H Geyeregger H Stockinger GJ Zlabinger W Waldhausl TM Stulnig 2003 Suppression of T cell signaling by polyunsaturated fatty acids: selectivity in inhibition of mitogen-activated protein kinase and nuclear factor activation J Immunol 170 6033 6039
25. SD Clarke 2001 Polyunsaturated fatty acid regulation of gene transcription: a molecular mechanism to improve the metabolic syndrome J Nutr 131 1129 1132
26. S Raza Shaikh M Edidin 2007 Immunosuppressive effects of polyunsaturated fatty acids on antigen presentation by human leukocyte antigen class I molecules J Lipid Res 48 127 138
27. JL Arrington RS Chapkin KC Switzer JS Morris DN McMurray 2001 Dietary n-3 polyunsaturated fatty acids modulate purified murine T-cell subset activation Clin Exp Immunol 123 1 10
28. KC Switzer DN McMurray JS Morris RS Chapkin 2003 N-3 polyunsaturated fatty acids promote activation-induced cell death in murine T lymphocytes J Nutr 133 496 503
29. MS Williams PA Henkart 1996 Role of reactive oxygen intermediates in TCR-induced death of T cell blasts and hybridomas J Immunol 157 2395 2402
30. DA Hildeman T Mitchell TK Teague 1999 Reactive oxygen species regulate activation-induced T cell apoptosis Immunity 10 735 744
31. AP Cope 2002 Studies of T-cell activation in chronic inflammation Arthritis Res 4 197 211
32. D Aronson 2008 Hyperglycemia and the pathobiology of diabetic complications Adv Cardiol 45 1 16
33. S Merzouk A Hichami S Madani H Merzouk A Yahia Berrouiguet J Prost K Moutairou N Chabane-Sari NA Khan 2003 Antioxidant status and levels of different vitamins determined by HPLC in diabetic subjects with multiple complications Gen Physiol Biophys 22 15 27
34. S Merzouk A Hichami A Sari S Madani H Merzouk A Yahia Berrouiguet JJ Lenoir-Rousseaux N Chabane-Sari NA Khan 2004 Impaired oxidant/antioxidant status and LDL-fatty acid composition are associated with increased susceptibility to peroxidation of LDL in diabetic patients Gen Physiol Biophys 23 387 399
35. P Purasiri A Mckechnie SD Heys O Eremin 1997 Modulation in vitro of human natural cytotoxicity, lymphocyte proliferative response to mitogens and cytokine production by essential fatty acids Immunology 92 166 172
36. T Mosmann 1983 Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J Immunol Methods 65 55 63
37. EG Bligh WJ Dyer 1959 A rapid method of total lipid extraction and purification Can J Physiol Pharmacol 37 911 917
38. Aebi H (1974) Catalase. In: H U Bergmeyer (ed) Methods of enzymatic analysis, 2nd edn. Verlag Chemie GmbH, Weinheim, pp 673-684
39. Elstner EF, Youngman RJ, Obwald W (1983) Superoxide dismutase. In: H U Bergmeyer (ed) Methods of enzymatic analysis, 3rd edn. Verlag Chemie GmbH, Weinheim, vol 3 pp 293-302
40. J Nourooz-Zadeh J Tajaddini-Sarmadi KLE Ling PS Wolff 1996 Low-density lipoprotein is the major carrier of lipid hydroperoxides in plasma. Relevance to determination of total plasma lipid hydroperoxide concentrations Biochem J 313 781 786
41. C Chen WH Lee P Yun P Snow CP Liu 2003 Induction of autoantigen-specific Th2 and Tr1 regulatory T cells and modulation of autoimmune diabetes J Immunol 171 733 744
42. A Kretowski J Mysliwiec M Szelachowska M Kinalski I Kinalska 1999 Insulin increases in vitro production of Th2 profile cytokines in peripheral blood cultures in subjects at high risk of diabetes type 1 and patients with newly diagnosed IDDM Horm Metab Res 31 289 -292
43. P Zhang R Smith RS Chapkin DN McMurray 2005 Dietary n-3 Polyunsaturated fatty acids modulate the Th1/Th2 balance towards the Th2 pole by suppression of Th1 development J Nutr 135 1745 1751
44. S Raza Shaikh M Edidin 2006 Polyunsaturated fatty acids, membrane organization, T cells, and antigen presentation Am J Clin Nutr 84 1277 1289
45. YY Fan LH Ly R Barhoumi DN McMurray RS Chapkin 2004 Dietary docosahexaenoic acid suppresses T-cell protein kinase C-theta lipid raft recruitment and interleukin-2 production J Immunol 173 6151 6160
46. P Yaqoob EA Newsholme PC Calder 1995 Influence of cell culture conditions on diet-induced changes in lymphocyte fatty acid composition Biochim Biophys Acta 1255 333 340
47. RK Fidelus MF Tsan 1986 Enhancement of intracellular glutathione promotes lymphocyte activation by mitogen Cell Immunol 97 155 163